|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 375.43 USD | -0.41% |
|
-0.42% | +14.70% |
| 11/03 | Equinix, Inc. Appoints Olivier Leonetti as Chief Financial Officer, Effective March 16, 2026 | CI |
| 09/03 | Global drugmakers rush to boost US presence as tariff threat looms | RE |
Company Valuation: Amgen Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 1,26,718 | 1,40,139 | 1,54,142 | 1,40,103 | 1,76,250 | 2,02,382 | - | - |
| Change | - | 10.59% | 9.99% | -9.11% | 25.8% | 14.83% | - | - |
| Enterprise Value (EV) 1 | 1,51,990 | 1,69,779 | 2,07,811 | 1,88,229 | 2,21,725 | 2,41,933 | 2,35,326 | 2,28,628 |
| Change | - | 11.7% | 22.4% | -9.42% | 17.8% | 9.11% | -2.73% | -2.85% |
| P/E ratio | 21.9x | 21.7x | 23.1x | 34.5x | 23x | 25.3x | 23.3x | 21.4x |
| PBR | 18.7x | 38.3x | 24.7x | 23.8x | 20.4x | 17x | 13.2x | 9.87x |
| PEG | - | 1.2x | 7.36x | -0.9x | 0.3x | 5.67x | 2.77x | 2.36x |
| Capitalization / Revenue | 4.88x | 5.32x | 5.47x | 4.19x | 4.8x | 5.35x | 5.22x | 5.11x |
| EV / Revenue | 5.85x | 6.45x | 7.37x | 5.63x | 6.03x | 6.39x | 6.07x | 5.77x |
| EV / EBITDA | 9.61x | 10.5x | 11.9x | 9.13x | 10.4x | 11.4x | 10.8x | 10.3x |
| EV / EBIT | 12.2x | 13.3x | 15.5x | 12.5x | 13.7x | 14.5x | 13.8x | 13.1x |
| EV / FCF | 18.1x | 19.3x | 28.2x | 18.1x | 27.4x | 19.5x | 18.5x | 17.1x |
| FCF Yield | 5.51% | 5.17% | 3.54% | 5.52% | 3.65% | 5.14% | 5.42% | 5.86% |
| Dividend per Share 2 | 7.04 | 7.76 | 8.52 | 9 | - | 10.04 | 10.72 | 11.43 |
| Rate of return | 3.13% | 2.95% | 2.96% | 3.45% | - | 2.67% | 2.86% | 3.05% |
| EPS 2 | 10.28 | 12.11 | 12.49 | 7.56 | 14.23 | 14.86 | 16.11 | 17.58 |
| Distribution rate | 68.5% | 64.1% | 68.2% | 119% | - | 67.5% | 66.5% | 65.1% |
| Net sales 1 | 25,979 | 26,323 | 28,190 | 33,424 | 36,751 | 37,836 | 38,746 | 39,599 |
| EBITDA 1 | 15,822 | 16,178 | 17,470 | 20,620 | 21,370 | 21,278 | 21,840 | 22,196 |
| EBIT 1 | 12,424 | 12,761 | 13,399 | 15,028 | 16,203 | 16,661 | 17,025 | 17,450 |
| Net income 1 | 5,893 | 6,552 | 6,717 | 4,090 | 7,711 | 7,866 | 8,612 | 9,492 |
| Net Debt 1 | 25,272 | 29,640 | 53,669 | 48,126 | 45,475 | 39,550 | 32,944 | 26,245 |
| Reference price 2 | 224.97 | 262.64 | 288.02 | 260.64 | 327.31 | 375.43 | 375.43 | 375.43 |
| Nbr of stocks (in thousands) | 5,63,266 | 5,33,579 | 5,35,178 | 5,37,533 | 5,38,481 | 5,39,068 | - | - |
| Announcement Date | 07/02/22 | 31/01/23 | 06/02/24 | 04/02/25 | 03/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 25.26x | 6.39x | 11.37x | 2.67% | 20TCr | ||
| 29.43x | 11.08x | 22.26x | 0.66% | 89TCr | ||
| 25.86x | 6.02x | 16.39x | 2.17% | 59TCr | ||
| 24.65x | 6.75x | 13.55x | 3.05% | 40TCr | ||
| 18.04x | 4.39x | 10.87x | 3% | 35TCr | ||
| 21.41x | 5.76x | 14.24x | 2.81% | 30TCr | ||
| 24.8x | 5.16x | 14.3x | 1.69% | 31TCr | ||
| 27.37x | 4.79x | 14.99x | 2.88% | 29TCr | ||
| 20.59x | 6.26x | 11.33x | 2.19% | 18TCr | ||
| 11.53x | 4.21x | 8.77x | 4.36% | 17TCr | ||
| Average | 22.90x | 6.08x | 13.81x | 2.55% | 36.81TCr | |
| Weighted average by Cap. | 24.57x | 6.94x | 15.65x | 2.18% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- AMGN Stock
- Valuation Amgen Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















